Masaomi Iyo mainly investigates Internal medicine, Endocrinology, Pharmacology, Psychosis and Schizophrenia. The concepts of her Internal medicine study are interwoven with issues in Glutamine, Psychiatry and Positron emission tomography. Masaomi Iyo interconnects Neuroscience, Serine and Serotonin in the investigation of issues within Endocrinology.
Masaomi Iyo has researched Pharmacology in several fields, including Fluvoxamine, NMDA receptor, Receptor, Phencyclidine and Receptor antagonist. Her Psychosis research is multidisciplinary, incorporating perspectives in Aripiprazole, Methamphetamine, Biochemistry, Neuropeptide S receptor and Antipsychotic. Her Schizophrenia research integrates issues from Tropisetron, 5-HT receptor, Anxiety disorder, Prefrontal cortex and Neurocognitive.
Masaomi Iyo focuses on Internal medicine, Endocrinology, Psychiatry, Schizophrenia and Psychosis. Her studies in Internal medicine integrate themes in fields like Neuroscience and Oncology. Within one scientific family, Masaomi Iyo focuses on topics pertaining to Serine under Endocrinology, and may sometimes address concerns connected to Glycine.
Her Psychiatry study which covers Clinical psychology that intersects with Cognition. Her Schizophrenia research incorporates themes from Case-control study, Bioinformatics and Candidate gene. Her Psychosis study combines topics in areas such as Tardive dyskinesia, Methamphetamine, Dopamine, Risperidone and Single-nucleotide polymorphism.
Masaomi Iyo mostly deals with Schizophrenia, Internal medicine, Psychiatry, Psychosis and Clinical psychology. Her Schizophrenia study integrates concerns from other disciplines, such as Single-nucleotide polymorphism and Psychopathology. Her research in Internal medicine intersects with topics in Endocrinology, Depression, Oncology and Positive and Negative Syndrome Scale.
The various areas that Masaomi Iyo examines in her Endocrinology study include Glutamate receptor, Homovanillic acid and Learned helplessness. Her research investigates the connection between Psychiatry and topics such as Randomized controlled trial that intersect with problems in Social anxiety. Her Psychosis study incorporates themes from Aripiprazole, Paliperidone, Dopamine and Pediatrics.
Her primary areas of investigation include Psychiatry, Schizophrenia, Psychosis, Internal medicine and Antipsychotic. Her Psychiatry research is multidisciplinary, relying on both Randomized controlled trial and Clinical psychology. Masaomi Iyo combines subjects such as rs4680, Aripiprazole, Dopamine receptor D2, Dopamine and Pediatrics with her study of Psychosis.
Her Internal medicine research includes themes of Endocrinology, Depression, Placebo, Lurasidone and Positive and Negative Syndrome Scale. Masaomi Iyo works in the field of Endocrinology, focusing on Tumor necrosis factor alpha in particular. In her research on the topic of Antipsychotic, Pharmacology and Risperidone is strongly related with Tardive dyskinesia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
Eiji Shimizu;Kenji Hashimoto;Naoe Okamura;Kaori Koike.
Biological Psychiatry (2003)
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Yoshiro Okubo;Yoshiro Okubo;Tetsuya Suhara;Kazutoshi Suzuki;Kaoru Kobayashi.
Nature (1997)
Critical role of brain-derived neurotrophic factor in mood disorders
Kenji Hashimoto;Eiji Shimizu;Masaomi Iyo.
Brain Research Reviews (2004)
Increased levels of glutamate in brains from patients with mood disorders.
Kenji Hashimoto;Akira Sawa;Masaomi Iyo.
Biological Psychiatry (2007)
Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Kenji Hashimoto;Takeshi Fukushima;Eiji Shimizu;Naoya Komatsu.
Archives of General Psychiatry (2003)
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
Kimiyoshi Ozawa;Kenji Hashimoto;Takashi Kishimoto;Eiji Shimizu.
Biological Psychiatry (2006)
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Yoshimoto Sekine;Masaomi Iyo;Yasuomi Ouchi;Tsutomu Matsunaga.
American Journal of Psychiatry (2001)
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits
Eiji Shimizu;Kenji Hashimoto;Masaomi Iyo.
American Journal of Medical Genetics (2004)
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
Masaomi Iyo;Hiroki Namba;Kiyoshi Fukushi;Hitoshi Shinotoh;Hitoshi Shinotoh.
The Lancet (1997)
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Yoshimoto Sekine;Yasuomi Ouchi;Nori Takei;Etsuji Yoshikawa.
Archives of General Psychiatry (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chiba University
Nagoya University
Kobe University
Fujita Health University
Teikyo University
Kanazawa University
National Institutes for Quantum and Radiological Science and Technology
Fujita Health University
RIKEN Center for Brain Science
National Center of Neurology and Psychiatry
Polytechnic University of Turin
University of Potsdam
Tianjin University
University of Ferrara
Institut Pasteur
KU Leuven
University of California, Irvine
University of Manchester
Saarland University
University of Hawaii at Manoa
University of Aveiro
University of Melbourne
University of Western Ontario
Harvard University
Mayo Clinic